| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
46,213 |
29,640 |
$4.46M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
36,982 |
25,076 |
$4.11M |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
6,370 |
5,301 |
$242K |
| 90837 |
Psychotherapy, 53 minutes with patient |
1,629 |
703 |
$191K |
| J0741 |
Injection, cabotegravir and rilpivirine, 2mg/3mg |
37 |
36 |
$184K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,054 |
1,075 |
$174K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,503 |
960 |
$159K |
| 80305 |
|
12,238 |
11,411 |
$149K |
| J0739 |
Injection, cabotegravir, 1mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv) |
42 |
40 |
$140K |
| 99215 |
Prolong outpt/office vis |
798 |
524 |
$100K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,452 |
2,781 |
$85K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
4,049 |
4,014 |
$65K |
| S5102 |
Day care services, adult; per diem |
537 |
68 |
$65K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
596 |
389 |
$57K |
| 90834 |
Psychotherapy, 45 minutes with patient |
552 |
318 |
$54K |
| 99441 |
|
696 |
379 |
$50K |
| 98968 |
|
516 |
239 |
$42K |
| 99406 |
|
2,822 |
2,729 |
$34K |
| 90832 |
Psychotherapy, 30 minutes with patient |
326 |
193 |
$30K |
| 90686 |
|
1,541 |
1,532 |
$29K |
| 97803 |
|
322 |
215 |
$21K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,421 |
1,176 |
$20K |
| 96127 |
|
3,565 |
3,535 |
$20K |
| 99442 |
|
281 |
181 |
$19K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
150 |
92 |
$19K |
| 90750 |
|
94 |
94 |
$16K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
473 |
462 |
$13K |
| 0031A |
|
290 |
289 |
$11K |
| 0012A |
|
290 |
290 |
$9K |
| S0612 |
Annual gynecological examination, established patient |
69 |
69 |
$8K |
| 0002A |
|
191 |
191 |
$7K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
65 |
32 |
$7K |
| 90677 |
|
25 |
25 |
$7K |
| 76830 |
Ultrasound, transvaginal |
74 |
74 |
$6K |
| 0001A |
|
169 |
167 |
$6K |
| 91322 |
|
39 |
39 |
$5K |
| 0011A |
|
358 |
358 |
$5K |
| G0467 |
Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit |
42 |
41 |
$5K |
| 91320 |
|
35 |
35 |
$4K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
35 |
24 |
$4K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
285 |
284 |
$3K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
64 |
64 |
$3K |
| 90480 |
|
73 |
73 |
$3K |
| 0004A |
|
70 |
70 |
$3K |
| 98967 |
|
31 |
12 |
$2K |
| 99051 |
|
255 |
242 |
$2K |
| 90732 |
|
12 |
12 |
$1K |
| 90715 |
|
27 |
27 |
$1K |
| 91301 |
|
41 |
36 |
$696.91 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
15 |
14 |
$687.57 |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
24 |
24 |
$611.65 |
| Q0144 |
Azithromycin dihydrate, oral, capsules/powder, 1 gram |
19 |
19 |
$370.97 |
| 99401 |
|
14 |
14 |
$354.67 |
| 99408 |
|
12 |
12 |
$251.65 |
| 96160 |
|
70 |
70 |
$203.73 |
| 87210 |
|
28 |
27 |
$129.40 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
12 |
12 |
$7.27 |
| 94760 |
|
18 |
17 |
$4.71 |
| 91300 |
|
70 |
68 |
$0.01 |
| 99000 |
|
51 |
51 |
$0.00 |
| 91303 |
|
30 |
30 |
$0.00 |
| 91305 |
|
12 |
12 |
$0.00 |